Domperidone 10 mg Orodispersible Tablet

Prednisolone is highly effective and signifi cantly more effective that Non-Steroidal Anti-Infl ammatory Drugs (NSAIDs) in rheumatoid arthritis and may be used intermittently1.n Prednisolone is the active metabolite of prednisone and prednisone’s effi cacy is related to the patient’s hepatic func...

n Racecadotril is a guideline-recommended treatment to alleviate symptoms of acute diarrhoea1, 2, 3. Safety profile is similar to that of placebo. Racecadotril inhibits the degradation of enkephalins, which in turn have potent antisecretory activity but only little effect on motility in the gut i...

Next-generation 5-nitroimidazole prodrug granted priority review by the FDA with longer half-life (17h) allowing for a once-daily dosing.n Secnidazole has similar activity against the range of microorganisms associated with bacterial vaginosis compared to metronidazole or tinidazole whilst sparin...

Fixed-combination of two well-known and established analgesics, devoid of the gastrointestinal, cardiovascular and renal adverse events associated with Non-Steroidal Anti-inflammatory Drugs (NSAIDs) responsible for 3.500-16.500 death per year in the USA1, 2.n Fixed-dose combination treatment redu...

Zolpidem is particularly suitable for insomniac patient suffering with difficulties with sleep initiation

1. Bilastine is a potent, effective antihistamine, without sedation, without cardiac toxicity, it has absence of metabolism and does not interact with cytochrome P4502.2. In experimental models, Bilastine has shown an excellent dose-dependent activity when administered by oral or intravenous rout...

Lesser behaviour deterioration vs. Galantamine14.n Superior Global Responder Rate vs. Galantamine14.n Lower risk of treatment withdrawals for any reason or because of an adverse event for Donepezil vs. Rivastigmine or Galantamine14

First single stereospecific S-isomer of omeprazole less prone to first-pass metabolism1.n Higher bioavailability than omeprazole2.n Superior acid control compared with all other Proton Pump Inhibitors (omeprazole, pantoprazole, lansoprazole & rabeprazole)3, 4, 

Anxiolytic effect equivalent to lorazepam, a higher responder rate, and a lower rate of rebound anxiety at treatment discontinuation (one week) in patients receiving etifoxine5.

Fenofibrate is a third generation fibric acid practically insoluble in water, making it challenging to consistently achieve therapeutic levels1, 2. Micronization technology dramatically improves the dissolution rate-limited gastrointestinal absorption.

Rated as the safest non-steroidal anti-inflammatory Drug by spontaneous adverse drug reaction reporting in the UK1, 2.n Prominent analgesic & antipyretic activities particularly useful in the management of pain related to dysmenorrhea, headache, postoperative dental pain and rheumatoid arthritis3....

n Levocetirizine efficacy superior to loratadine, desloratadine and fexofenadine3, 4, 5, 6, 7, 8.n 43% saving on the social cost of persistent allergic rhinitis9.n Minimal impairment of memory and psychomotor functioning nor mood changes after acute and sub chronic administration of levocetirizine10.

The purpose of this section, is to give to the audience some advice and warnings on how to better develop and produce a customized drug delivery medical device, based on our own experience. in fact the pathway for a new drug delivery medical device, is full of the unexpected and sometimes the company has to stop the development phase so they never get to production or they spend a lot more money and time compared to a better path/arrangement. There will be also examples and case studies taken from our own experience. The other purpose of this section, is to show you the advantages of a customer centric and multidisciplinary approach to develop and produce a customized drug delivery device.